1Anderson WF, Matsuno R. Breast cancer heterogeneity : a mixture of at least two main types[J]. J Natl Cancer Inst,2006,98(14) :948.
2Perou CM, Sorlie T, Eisen MB, et al. Molecular portraits of human breast tumours[ J]. Nature ,2000,406 ( 6797 ) :747.
3Weigelt B, Horlings HM, Kreike B, et al. Refinement of breast cancer classification by molecular characterization of histological special types [ J]. J Pathol,2008,216 (2) : 141.
4Sotiriou C, Pusztai L. Gene-Expression Signatures in Breast Cancer [J]. N Engl J Med,2009,360(8) :790.
5Early Breast Cancer Trialists'Collaborative Group. Tamoxifen for early breast cancer:An overview of the randomised trials [ J ]. Lancet, 1998, 351 (9114) :1451.
6Sparano JA, Paik S. Development of the 21 -gene assay and its applica- tion in clinical practice and clinical trials[ J]. J Clin Onco1,2008,26 (5) :721.
7Paik S, Tang G, Shak S, et al. Gene expression and benefit of chemo- therapy in women with node- negative, estrogen receptor positive breast cancer[ J ]. J Clin Onco1,2006,24 (23):3726.
8Benz CC, Scott GK, Sarnp JC, et al. Estrogen-dependent, tamoxifen-re- sistant tumorigenic growth of MCF-7 cells transfected with HER2/neu [J]. Breast Cancer Res Treat,1992,24(2) :85.
9Ellis MJ, Coop A, Singh B, et al. Letrozole is more effective neoadju- vant endocrine therapy than tamoxifen for ErbB-1 - and/or ErbB-2 - positive, estrogen receptor - positive primary-breast cancer: evi- dence from a phase Ⅲ randomized trial [ J ]. J Clin Oneol, 2001,19 (18) :3808.
10Smith IE, Dowsett M, Ebbs SR, et al. Neoadjuvant treatment of postm- enopausal breast cancer with anastrozole, tamoxifen, or both in combi- nation : the immediate preoperative anastrozole, tamoxifen, or combined with tamoxifen (IMPACT) multicenter double-blind randomized trial [ J ]. J Clin Onco1,2005,23 ( 22 ) :5108.
5Gupta S, Afaq F, Mukhtar H. Involvement of nuclear factor-kappa B, Bax and Bcl-2 in induction of cell cycle arrest and apoptosis by apigenin in human prostate carcinoma cells[J]. Oncogene, 2002, 21(23):3727-3738.
6Nguyen TT, Tran E, Nguyen TH, et al. The role of activated MEK- ERK pathway in quercetin induced growth inhibition and apoptosis in A549 lung cancer cell[J]. Carcinogenesis, 2004, 25(5):647-659.
7Khan N, Afaq F, Syed DN, et al. Fisetin, a novel dietary flavonoid, causes apoptosis and cell cycle arrest in human prostate cancer LNCaP cells[J]. Carcinogenesis, 2008, 29(5): 1049-1056.
8Ng G, Huang J. The significance of autophagy in cancer[J]. Mol Carcinog, 2005, 43(4): 183-187.
9Li J, Hou N, Faried A, et al. Inhibition of autophagy by 3-MA enhances the effect of 5-FU-induced apoptosis in colon cancer cells [J]. Ann Surg Oncol, 2009, 16(3):761-771.
10Maiuri MC, Zalckvar E, Kinchi A, et al. Self-eating and self-killing: crosstalk between autophagy and apoptosis[J]. Nat Rev Mol Cell Biol, 2007, 8(9):741-752.
